| 1. |
- Thomas, HS, et al.
(author)
-
- 2019
-
swepub:Mat__t
|
|
| 2. |
|
|
| 3. |
|
|
| 4. |
- Alqeeq, S. W., et al.
(author)
-
Investigation of the homogeneity of energy conversion processes at dipolarization fronts from MMS measurements
- 2022
-
In: Physics of Plasmas. - : American Institute of Physics (AIP). - 1070-664X .- 1089-7674. ; 29:1
-
Journal article (peer-reviewed)abstract
- We report on six dipolarization fronts (DFs) embedded in fast earthward flows detected by the Magnetospheric Multiscale mission during a substorm event on 23 July 2017. We analyzed Ohm's law for each event and found that ions are mostly decoupled from the magnetic field by Hall fields. However, the electron pressure gradient term is also contributing to the ion decoupling and likely responsible for an electron decoupling at DF. We also analyzed the energy conversion process and found that the energy in the spacecraft frame is transferred from the electromagnetic field to the plasma (J & BULL; E > 0) ahead or at the DF, whereas it is the opposite (J & BULL; E < 0) behind the front. This reversal is mainly due to a local reversal of the cross-tail current indicating a substructure of the DF. In the fluid frame, we found that the energy is mostly transferred from the plasma to the electromagnetic field (J & BULL; E & PRIME; < 0) and should contribute to the deceleration of the fast flow. However, we show that the energy conversion process is not homogeneous at the electron scales due to electric field fluctuations likely related to lower-hybrid drift waves. Our results suggest that the role of DF in the global energy cycle of the magnetosphere still deserves more investigation. In particular, statistical studies on DF are required to be carried out with caution due to these electron scale substructures.
|
|
| 5. |
|
|
| 6. |
- Mikomangwa, WP, et al.
(author)
-
Effect of sulfadoxine-pyrimethamine doses for prevention of malaria during pregnancy in hypoendemic area in Tanzania
- 2020
-
In: Malaria journal. - : Springer Science and Business Media LLC. - 1475-2875. ; 19:1, s. 160-
-
Journal article (peer-reviewed)abstract
- BackgroundMalaria in pregnancy increases the risk of deleterious maternal and birth outcomes. The use of ≥ 3 doses of sulfadoxine-pyrimethamine (SP) for intermittent preventive treatment of malaria (IPTp-SP) is recommended for preventing the consequences of malaria during pregnancy. This study assessed the effect of IPTp-SP for prevention of malaria during pregnancy in low transmission settings.MethodsA cross-sectional study that involved consecutively selected 1161 pregnant women was conducted at Mwananyamala regional referral hospital in Dar es Salaam. Assessment of the uptake of IPTp-SP was done by extracting information from antenatal clinic cards. Maternal venous blood, cord blood, placental blood and placental biopsy were collected for assessment of anaemia and malaria. High performance liquid chromatography with ultraviolet detection (HPLC-UV) was used to detect and quantify sulfadoxine (SDX). Dried blood spots (DBS) of placental blood were collected for determination of sub-microscopic malaria using polymerase chain reaction (PCR).ResultsIn total, 397 (34.2%) pregnant women reported to have used sub-optimal doses (≤ 2) while 764 (65.8%) used optimal doses (≥ 3) of IPTp-SP at the time of delivery. The prevalence of placental malaria as determined by histology was 3.6%. Submicroscopic placental malaria was detected in 1.4% of the study participants. Women with peripheral malaria had six times risk of maternal anaemia than those who were malaria negative (aOR, 5.83; 95% CI 1.10–30.92; p = 0.04). The geometric mean plasma SDX concentration was 10.76 ± 2.51 μg/mL. Sub-optimal IPTp-SP dose was not associated with placental malaria, premature delivery and fetal anaemia. The use of ≤ 2 doses of IPTp-SP increased the risk of maternal anaemia by 1.36-fold compared to ≥ 3 doses (aOR, 1.36; 95% CI 1.04–1.79; p = 0.02).ConclusionThe use of < 2 doses of IPTp-SP increased the risk of maternal anaemia. However, sub-optimal doses (≤ 2 doses) were not associated with increased the risk of malaria parasitaemia, fetal anaemia and preterm delivery among pregnant women in low malaria transmission setting. The use of optimal doses (≥ 3 doses) of IPTp-SP and complementary interventions should continue even in areas with low malaria transmission.
|
|
